Need CE fast? We’ve got you covered.
If you’ve waited until the last minute to complete your CE requirements, get caught up with us on December 31. We’ll be offering the following courses:
P <795> – Keys to Compliance with the 2022 Updates in Nonsterile Compounding Standards
Steven Ziegler, PharmD, MBA | 8:00 AM ET
USP <795> nonsterile compounding standards have recently been revised and approved for implementation in November 2022. This new revision brings many changes that will impact all facilities that compound nonsterile compounds for human and animal patients. This session seeks to discuss the key changes in the USP <795> standards, identify challenges to addressing and implementing these changes, and discuss some strategies for implementing the changes successfully.
Learning objectives:
- Identify the changes in USP <795> presented in the 2022 standards
- Identify the challenges to implementation of the 2022 USP <795> standards
- Identify strategies to address the challenges to implementation of the 2022 USP <795> standards
- Identify deadlines for compliance with the 2022 USP <795> standards
Drug Supply Chain Security Act Overview
John Malek, RPh, JD, MA | 11:30 AM ET
Pharmacy personnel need to completely understand their responsibilities under the Drug Supply Chain Security Act (DSCSA) to protect patients from receiving potentially harmful products. The DSCSA includes specific requirements that pharmacies must follow to prevent the introduction of counterfeit or illegitimate drugs to the marketplace. This session will evaluate the responsibilities of the pharmacy, including prevention, detection, and response initiatives.
Learning objectives:
- Recognize the intent and purpose of the Drug Supply Chain Security Act (DSCSA)
- Cite best pharmacy practice standards to maintain compliance with the Drug Supply Chain Security Act (DSCSA)
- Identify areas of traditional pharmacy practice that will be impacted by the implementation of the Drug Supply Chain Security Act (DSCSA)
The Updated COVID-19 2023-2024 Vaccines: Staying Informed For Another Respiratory Season
Krista Capehart, PharmD, MSPharm, BCACP, AE-C | 1:00 PM ET
This program provides an overview of mRNA COVID-19 vaccines and a crucial update on the 2023-2024 COVID-19 new products and dosages. Recommendations for those 6 months and up, both immunocompromised and not, will be covered.
Learning objectives:
- Describe the mechanism of action of the XBB.1.5-adapted monovalent approved and authorized COVID-19 vaccines
- Identify the appropriate Centers for Disease Control (CDC) Updated COVID-19 2023-2024 vaccine recommendations for the Pfizer-BioNTech and Moderna vaccine for ages 6 months and older
- Recognize appropriate recommendations for CDC Updated COVID-19 2023-2024 vaccines for moderate to severely immunocompromised
- Identify adverse events with the Updated COVID-19 2023-2024 vaccines
Become a free CE member today to get unlimited access to all the CE you need
In a world where the healthcare landscape is constantly evolving, freeCE stands out as the ideal choice for pharmacists and pharmacy technicians seeking to meet their continuing education requirements.
What sets us apart is our commitment to affordability, offering high-quality education without breaking the bank. With an extensive catalog of courses, both live and on-demand, we cater to diverse interests and needs, ensuring that you’ll find the perfect fit for your professional growth.
When you choose freeCE, you’re not just choosing a CE provider; you’re selecting a partner in your journey towards excellence in pharmacy. Join us today and experience the difference for yourself – affordable, comprehensive, and engaging education at your fingertips.
